Poxel to Present New Imeglimin Data at the 9th Scientific Meeting of the Asian Association for the Study of Diabetes in Japan Apr 20, 2017
Poxel Announces Appointment of Christophe Arbet-Engels, MD, PhD, MBA, as Chief Medical Officer and EVP Late Development & Medical Affairs, Based in Boston Mar 7, 2017
Poxel Announces Phase 1 Initiation of EYP001 for the Treatment of Chronic Hepatitis B Virus Infection by Licensing Partner ENYO Pharma SA Dec 19, 2016
Ability to Delay Type 2 Diabetes Disease Progression by Preserving Beta Cell Mass Observed in New Imeglimin Data Dec 5, 2016
Poxel to Present New Imeglimin Data Demonstrating Beta Cell Function Preservation at the 14th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease Nov 21, 2016
